HK Stock MarketDetailed Quotes

BYD COMPANY-R (81211)

Watchlist
  • 88.650
  • -0.150-0.17%
Market Closed Jan 16 15:55 CST
808.24BMarket Cap21.08P/E (TTM)

Earnings

Revenue Breakdown

Business Data

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BYD COMPANY-R (81211) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Turnover
12.75%566.27B
23.30%371.28B
36.35%170.36B
29.02%777.1B
18.94%502.25B
15.76%301.13B
3.97%124.94B
42.04%602.32B
57.75%422.27B
72.72%260.12B
Operating income
12.75%566.27B
23.30%371.28B
36.35%170.36B
29.02%777.1B
18.94%502.25B
15.76%301.13B
3.97%124.94B
42.04%602.32B
57.75%422.27B
72.72%260.12B
Operating expenses
-14.76%-465.05B
-24.47%-304.42B
-37.45%-136.18B
-27.66%-626.05B
-19.63%-405.23B
-15.12%-244.58B
-0.37%-99.07B
-39.39%-490.4B
-50.45%-338.73B
-63.09%-212.45B
Gross profit
4.32%101.21B
18.24%66.87B
32.14%34.19B
34.97%151.06B
16.12%97.02B
18.62%56.55B
20.51%25.87B
54.91%111.92B
96.39%83.55B
134.36%47.67B
Selling expenses
-11.21%-18.51B
-17.09%-12.41B
-15.91%-6.18B
-56.70%-24.09B
3.39%-16.64B
2.20%-10.6B
-14.72%-5.33B
-2.06%-15.37B
-84.13%-17.23B
-129.49%-10.84B
Administrative expenses
-23.04%-15.27B
-34.97%-10.39B
-30.18%-4.91B
-38.50%-18.64B
-20.71%-12.41B
-12.85%-7.69B
-11.97%-3.77B
-34.52%-13.46B
-60.39%-10.28B
-85.77%-6.82B
Research and development expenses
-31.30%-43.75B
-50.84%-29.6B
-34.04%-14.22B
-34.42%-53.19B
-33.61%-33.32B
-41.82%-19.62B
-70.10%-10.61B
-112.15%-39.57B
-129.42%-24.94B
-155.05%-13.83B
Profit from asset sales
129.96%11.24M
-109.69%-17.63M
168.53%2.94M
-240.02%-126.53M
-130.45%-37.51M
-111.10%-8.41M
-110.22%-4.29M
933.92%90.36M
671.13%123.17M
415.11%75.77M
Revaluation surplus
40.70%557.02M
7.40%373.46M
72.50%246.27M
106.38%531.93M
48.35%395.89M
300.16%347.72M
76.99%142.76M
104.40%257.74M
661.05%266.86M
641.71%86.9M
-Changes in the fair value of other assets
40.70%557.02M
7.40%373.46M
72.50%246.27M
106.38%531.93M
48.35%395.89M
300.16%347.72M
76.99%142.76M
104.40%257.74M
661.05%266.86M
641.71%86.9M
Impairment and provision
48.56%-1.93B
41.52%-1.36B
24.32%-733.51M
-43.98%-5.42B
-54.37%-3.75B
-53.10%-2.32B
-34.25%-969.17M
-58.58%-3.77B
-67.68%-2.43B
-129.60%-1.52B
-Other impairment is provision
48.56%-1.93B
41.52%-1.36B
24.32%-733.51M
-43.98%-5.42B
-54.37%-3.75B
-53.10%-2.32B
-34.25%-969.17M
-58.58%-3.77B
-67.68%-2.43B
-129.60%-1.52B
Special items of operating profit
15.07%12.56B
32.55%8B
65.20%3.99B
137.25%16.34B
187.52%10.91B
146.43%6.03B
159.13%2.42B
641.32%6.89B
363.46%3.8B
774.79%2.45B
Operating profit
-20.76%25.97B
-11.04%15.47B
62.59%9.11B
41.15%51.7B
29.21%32.77B
37.72%17.39B
5.66%5.6B
83.84%36.63B
136.05%25.37B
239.14%12.63B
Financing cost
385.83%2.94B
4,805.44%3.25B
883.88%1.91B
-182.46%-1.22B
-180.75%-1.03B
-106.26%-69.01M
3,381.91%193.96M
-8.84%1.47B
-5.05%1.27B
22.76%1.1B
Adjustment items of  earning before tax
42.45%-245.79M
300.24%190.51M
309.85%170.23M
3.49%-805.37M
25.32%-427.09M
71.29%-95.14M
0.30%-81.12M
-80.58%-834.46M
-1,794.66%-571.88M
-1,811.14%-331.36M
Earning before tax
-8.49%28.66B
9.76%18.91B
95.73%11.19B
33.30%49.68B
20.16%31.32B
28.57%17.23B
9.59%5.72B
76.80%37.27B
115.08%26.07B
188.70%13.4B
Tax
12.69%-4.43B
7.83%-2.87B
-84.66%-1.75B
-36.60%-8.09B
-35.65%-5.07B
-58.91%-3.11B
-11.71%-946.49M
-75.98%-5.92B
-75.48%-3.74B
-176.73%-1.96B
After-tax profit from continuing operations
-7.68%24.23B
13.64%16.04B
97.93%9.44B
32.68%41.59B
17.56%26.25B
23.37%14.11B
9.17%4.77B
76.95%31.34B
123.52%22.33B
190.85%11.44B
Earning after tax
-7.68%24.23B
13.64%16.04B
97.93%9.44B
32.68%41.59B
17.56%26.25B
23.37%14.11B
9.17%4.77B
76.95%31.34B
123.52%22.33B
190.85%11.44B
Minority profit
-10.99%898.49M
9.64%528.41M
42.59%288.16M
2.33%1.33B
5.20%1.01B
-0.74%481.96M
-15.77%202.09M
19.49%1.3B
41.76%959.53M
43.72%485.57M
Profit attributable to shareholders
-7.55%23.33B
13.79%15.51B
100.38%9.15B
34.00%40.25B
18.12%25.24B
24.44%13.63B
10.62%4.57B
80.72%30.04B
129.47%21.37B
204.68%10.95B
Basic earnings per share
-11.42%2.56
9.62%1.71
98.73%3.12
34.11%13.84
-60.68%2.89
-58.62%1.56
10.56%1.57
80.74%10.32
129.69%7.35
204.03%3.77
Diluted earnings per share
-11.42%2.56
9.62%1.71
98.73%3.12
34.11%13.84
-60.68%2.89
-58.62%1.56
10.56%1.57
80.74%10.32
129.69%7.35
204.03%3.77
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Turnover 12.75%566.27B23.30%371.28B36.35%170.36B29.02%777.1B18.94%502.25B15.76%301.13B3.97%124.94B42.04%602.32B57.75%422.27B72.72%260.12B
Operating income 12.75%566.27B23.30%371.28B36.35%170.36B29.02%777.1B18.94%502.25B15.76%301.13B3.97%124.94B42.04%602.32B57.75%422.27B72.72%260.12B
Operating expenses -14.76%-465.05B-24.47%-304.42B-37.45%-136.18B-27.66%-626.05B-19.63%-405.23B-15.12%-244.58B-0.37%-99.07B-39.39%-490.4B-50.45%-338.73B-63.09%-212.45B
Gross profit 4.32%101.21B18.24%66.87B32.14%34.19B34.97%151.06B16.12%97.02B18.62%56.55B20.51%25.87B54.91%111.92B96.39%83.55B134.36%47.67B
Selling expenses -11.21%-18.51B-17.09%-12.41B-15.91%-6.18B-56.70%-24.09B3.39%-16.64B2.20%-10.6B-14.72%-5.33B-2.06%-15.37B-84.13%-17.23B-129.49%-10.84B
Administrative expenses -23.04%-15.27B-34.97%-10.39B-30.18%-4.91B-38.50%-18.64B-20.71%-12.41B-12.85%-7.69B-11.97%-3.77B-34.52%-13.46B-60.39%-10.28B-85.77%-6.82B
Research and development expenses -31.30%-43.75B-50.84%-29.6B-34.04%-14.22B-34.42%-53.19B-33.61%-33.32B-41.82%-19.62B-70.10%-10.61B-112.15%-39.57B-129.42%-24.94B-155.05%-13.83B
Profit from asset sales 129.96%11.24M-109.69%-17.63M168.53%2.94M-240.02%-126.53M-130.45%-37.51M-111.10%-8.41M-110.22%-4.29M933.92%90.36M671.13%123.17M415.11%75.77M
Revaluation surplus 40.70%557.02M7.40%373.46M72.50%246.27M106.38%531.93M48.35%395.89M300.16%347.72M76.99%142.76M104.40%257.74M661.05%266.86M641.71%86.9M
-Changes in the fair value of other assets 40.70%557.02M7.40%373.46M72.50%246.27M106.38%531.93M48.35%395.89M300.16%347.72M76.99%142.76M104.40%257.74M661.05%266.86M641.71%86.9M
Impairment and provision 48.56%-1.93B41.52%-1.36B24.32%-733.51M-43.98%-5.42B-54.37%-3.75B-53.10%-2.32B-34.25%-969.17M-58.58%-3.77B-67.68%-2.43B-129.60%-1.52B
-Other impairment is provision 48.56%-1.93B41.52%-1.36B24.32%-733.51M-43.98%-5.42B-54.37%-3.75B-53.10%-2.32B-34.25%-969.17M-58.58%-3.77B-67.68%-2.43B-129.60%-1.52B
Special items of operating profit 15.07%12.56B32.55%8B65.20%3.99B137.25%16.34B187.52%10.91B146.43%6.03B159.13%2.42B641.32%6.89B363.46%3.8B774.79%2.45B
Operating profit -20.76%25.97B-11.04%15.47B62.59%9.11B41.15%51.7B29.21%32.77B37.72%17.39B5.66%5.6B83.84%36.63B136.05%25.37B239.14%12.63B
Financing cost 385.83%2.94B4,805.44%3.25B883.88%1.91B-182.46%-1.22B-180.75%-1.03B-106.26%-69.01M3,381.91%193.96M-8.84%1.47B-5.05%1.27B22.76%1.1B
Adjustment items of  earning before tax 42.45%-245.79M300.24%190.51M309.85%170.23M3.49%-805.37M25.32%-427.09M71.29%-95.14M0.30%-81.12M-80.58%-834.46M-1,794.66%-571.88M-1,811.14%-331.36M
Earning before tax -8.49%28.66B9.76%18.91B95.73%11.19B33.30%49.68B20.16%31.32B28.57%17.23B9.59%5.72B76.80%37.27B115.08%26.07B188.70%13.4B
Tax 12.69%-4.43B7.83%-2.87B-84.66%-1.75B-36.60%-8.09B-35.65%-5.07B-58.91%-3.11B-11.71%-946.49M-75.98%-5.92B-75.48%-3.74B-176.73%-1.96B
After-tax profit from continuing operations -7.68%24.23B13.64%16.04B97.93%9.44B32.68%41.59B17.56%26.25B23.37%14.11B9.17%4.77B76.95%31.34B123.52%22.33B190.85%11.44B
Earning after tax -7.68%24.23B13.64%16.04B97.93%9.44B32.68%41.59B17.56%26.25B23.37%14.11B9.17%4.77B76.95%31.34B123.52%22.33B190.85%11.44B
Minority profit -10.99%898.49M9.64%528.41M42.59%288.16M2.33%1.33B5.20%1.01B-0.74%481.96M-15.77%202.09M19.49%1.3B41.76%959.53M43.72%485.57M
Profit attributable to shareholders -7.55%23.33B13.79%15.51B100.38%9.15B34.00%40.25B18.12%25.24B24.44%13.63B10.62%4.57B80.72%30.04B129.47%21.37B204.68%10.95B
Basic earnings per share -11.42%2.569.62%1.7198.73%3.1234.11%13.84-60.68%2.89-58.62%1.5610.56%1.5780.74%10.32129.69%7.35204.03%3.77
Diluted earnings per share -11.42%2.569.62%1.7198.73%3.1234.11%13.84-60.68%2.89-58.62%1.5610.56%1.5780.74%10.32129.69%7.35204.03%3.77
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
New Consumption Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.88%
Sample Name
Sample Code
 +6.48%
Sample Name
Sample Code
 +4.52%
4
GIANT BIOGENE
02367
+4.07%
5
BLOKS
00325
+2.72%
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More
Are you foolish? What's the point of knowing your mistakes?
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?

- No more -